These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 32883983)

  • 1. RFX5 promotes the progression of hepatocellular carcinoma through transcriptional activation of KDM4A.
    Chen DB; Xie XW; Zhao YJ; Wang XY; Liao WJ; Chen P; Deng KJ; Fei R; Qin WY; Wang JH; Wu X; Shao QX; Wei L; Chen HS
    Sci Rep; 2020 Sep; 10(1):14538. PubMed ID: 32883983
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulatory factor X5 promotes hepatocellular carcinoma progression by transactivating tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein theta and suppressing apoptosis.
    Chen DB; Zhao YJ; Wang XY; Liao WJ; Chen P; Deng KJ; Cong X; Fei R; Wu X; Shao QX; Wei L; Xie XW; Chen HS
    Chin Med J (Engl); 2019 Jul; 132(13):1572-1581. PubMed ID: 31188160
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The transcription factor RFX5 is a transcriptional activator of the TPP1 gene in hepatocellular carcinoma.
    Zhao Y; Xie X; Liao W; Zhang H; Cao H; Fei R; Wang X; Wei L; Shao Q; Chen H
    Oncol Rep; 2017 Jan; 37(1):289-296. PubMed ID: 27840983
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ZHX2 restricts hepatocellular carcinoma by suppressing stem cell-like traits through KDM2A-mediated H3K36 demethylation.
    Lin Q; Wu Z; Yue X; Yu X; Wang Z; Song X; Xu L; He Y; Ge Y; Tan S; Wang T; Song H; Yuan D; Gong Y; Gao L; Liang X; Ma C
    EBioMedicine; 2020 Mar; 53():102676. PubMed ID: 32114388
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Depletion of histone demethylase KDM5B inhibits cell proliferation of hepatocellular carcinoma by regulation of cell cycle checkpoint proteins p15 and p27.
    Wang D; Han S; Peng R; Jiao C; Wang X; Yang X; Yang R; Li X
    J Exp Clin Cancer Res; 2016 Feb; 35():37. PubMed ID: 26911146
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Histone demethylase KDM4A plays an oncogenic role in nasopharyngeal carcinoma by promoting cell migration and invasion.
    Zhao J; Li B; Ren Y; Liang T; Wang J; Zhai S; Zhang X; Zhou P; Zhang X; Pan Y; Gao F; Zhang S; Li L; Yang Y; Deng X; Li X; Chen L; Yang D; Zheng Y
    Exp Mol Med; 2021 Aug; 53(8):1207-1217. PubMed ID: 34385569
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased Expression of Lysine-Specific Demethylase 5B (KDM5B) Promotes Tumor Cell Growth in Hep3B Cells and is an Independent Prognostic Factor in Patients with Hepatocellular Carcinoma.
    Gong J; Yan S; Yu H; Zhang W; Zhang D
    Med Sci Monit; 2018 Oct; 24():7586-7594. PubMed ID: 30353907
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ETS transcription factor ERG cooperates with histone demethylase KDM4A.
    Kim TD; Shin S; Janknecht R
    Oncol Rep; 2016 Jun; 35(6):3679-88. PubMed ID: 27109047
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long non-coding RNA LINC01503 promotes the progression of hepatocellular carcinoma via activating MAPK/ERK pathway.
    Wang MR; Fang D; Di MP; Guan JL; Wang G; Liu L; Sheng JQ; Tian DA; Li PY
    Int J Med Sci; 2020; 17(9):1224-1234. PubMed ID: 32547318
    [No Abstract]   [Full Text] [Related]  

  • 10. Transcription Factor MafB Promotes Hepatocellular Carcinoma Cell Proliferation through Up-Regulation of Cyclin D1.
    Yu H; Jiang HL; Xu D; Jin JZ; Zhao ZM; Ma YD; Liang J
    Cell Physiol Biochem; 2016; 39(2):700-8. PubMed ID: 27448450
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lymphoid-specific helicase promotes the growth and invasion of hepatocellular carcinoma by transcriptional regulation of centromere protein F expression.
    Yang X; Miao BS; Wei CY; Dong RZ; Gao PT; Zhang XY; Lu JC; Gao C; Wang XY; Sun HC; Zhou J; Fan J; Ke AW; Shi GM; Cai JB
    Cancer Sci; 2019 Jul; 110(7):2133-2144. PubMed ID: 31066149
    [TBL] [Abstract][Full Text] [Related]  

  • 12. WTAP facilitates progression of hepatocellular carcinoma via m6A-HuR-dependent epigenetic silencing of ETS1.
    Chen Y; Peng C; Chen J; Chen D; Yang B; He B; Hu W; Zhang Y; Liu H; Dai L; Xie H; Zhou L; Wu J; Zheng S
    Mol Cancer; 2019 Aug; 18(1):127. PubMed ID: 31438961
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of KDM4A-mediated histone methylation on temozolomide resistance in glioma cells through the HUWE1/ROCK2 axis.
    Li XX; Xu JK; Su WJ; Wu HL; Zhao K; Zhang CM; Chen XK; Yang LX
    Kaohsiung J Med Sci; 2024 Feb; 40(2):161-174. PubMed ID: 37873881
    [TBL] [Abstract][Full Text] [Related]  

  • 14. KDM4B and KDM4A promote endometrial cancer progression by regulating androgen receptor, c-myc, and p27kip1.
    Qiu MT; Fan Q; Zhu Z; Kwan SY; Chen L; Chen JH; Ying ZL; Zhou Y; Gu W; Wang LH; Cheng WW; Zeng J; Wan XP; Mok SC; Wong KK; Bao W
    Oncotarget; 2015 Oct; 6(31):31702-20. PubMed ID: 26397136
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA-500a Promotes the Progression of Hepatocellular Carcinoma by Post-Transcriptionally Targeting BID.
    Bao L; Zhang M; Han S; Zhan Y; Guo W; Teng F; Liu F; Guo M; Zhang L; Ding G; Wang Q
    Cell Physiol Biochem; 2018; 47(5):2046-2055. PubMed ID: 29969781
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The long non-coding RNA PTTG3P promotes cell growth and metastasis via up-regulating PTTG1 and activating PI3K/AKT signaling in hepatocellular carcinoma.
    Huang JL; Cao SW; Ou QS; Yang B; Zheng SH; Tang J; Chen J; Hu YW; Zheng L; Wang Q
    Mol Cancer; 2018 May; 17(1):93. PubMed ID: 29803224
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MiR-10a functions as a tumor suppressor in prostate cancer via targeting KDM4A.
    Mu H; Xiang L; Li S; Rao D; Wang S; Yu K
    J Cell Biochem; 2019 Apr; 120(4):4987-4997. PubMed ID: 30302800
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical and biological significance of transcription termination factor, RNA polymerase I in human liver hepatocellular carcinoma.
    Komatsu H; Iguchi T; Ueda M; Nambara S; Saito T; Hirata H; Sakimura S; Takano Y; Uchi R; Shinden Y; Eguchi H; Masuda T; Sugimachi K; Eguchi H; Doki Y; Mori M; Mimori K
    Oncol Rep; 2016 Apr; 35(4):2073-80. PubMed ID: 26821084
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ATF3 inhibits the tumorigenesis and progression of hepatocellular carcinoma cells via upregulation of CYR61 expression.
    Chen C; Ge C; Liu Z; Li L; Zhao F; Tian H; Chen T; Li H; Yao M; Li J
    J Exp Clin Cancer Res; 2018 Oct; 37(1):263. PubMed ID: 30376856
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of miR-193a-5p in the proliferation and apoptosis of hepatocellular carcinoma.
    Wang JT; Wang ZH
    Eur Rev Med Pharmacol Sci; 2018 Nov; 22(21):7233-7239. PubMed ID: 30468466
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.